vs

Side-by-side financial comparison of Clorox (CLX) and Cognizant (CTSH). Click either name above to swap in a different company.

Cognizant is the larger business by last-quarter revenue ($5.4B vs $4.8B, roughly 1.1× Clorox). On growth, Cognizant posted the faster year-over-year revenue change (5.8% vs -6.7%). Clorox produced more free cash flow last quarter ($637.0M vs $198.0M). Over the past eight quarters, Clorox's revenue compounded faster (62.2% CAGR vs 5.6%).

The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.

Cognizant Technology Solutions Corporation is an American multinational information technology consulting and outsourcing company originally founded in India. It is headquartered in Teaneck, New Jersey, United States. Cognizant is part of the NASDAQ-100 and trades under CTSH. It was founded in Chennai, India, as an in-house technology unit of Dun & Bradstreet in 1994, and started serving external clients in 1996.

CLX vs CTSH — Head-to-Head

Bigger by revenue
CTSH
CTSH
1.1× larger
CTSH
$5.4B
$4.8B
CLX
Growing faster (revenue YoY)
CTSH
CTSH
+12.6% gap
CTSH
5.8%
-6.7%
CLX
More free cash flow
CLX
CLX
$439.0M more FCF
CLX
$637.0M
$198.0M
CTSH
Faster 2-yr revenue CAGR
CLX
CLX
Annualised
CLX
62.2%
5.6%
CTSH

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
CLX
CLX
CTSH
CTSH
Revenue
$4.8B
$5.4B
Net Profit
$662.0M
Gross Margin
Operating Margin
15.6%
Net Margin
12.2%
Revenue YoY
-6.7%
5.8%
Net Profit YoY
-0.2%
EPS (diluted)
$1.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLX
CLX
CTSH
CTSH
Q1 26
$4.8B
$5.4B
Q4 25
$1.7B
$5.3B
Q3 25
$5.4B
Q2 25
$2.0B
$5.2B
Q1 25
$1.7B
$5.1B
Q4 24
$1.7B
$5.1B
Q3 24
$1.8B
$5.0B
Q2 24
$1.9B
$4.8B
Net Profit
CLX
CLX
CTSH
CTSH
Q1 26
$662.0M
Q4 25
$157.0M
$648.0M
Q3 25
$274.0M
Q2 25
$332.0M
$645.0M
Q1 25
$186.0M
$663.0M
Q4 24
$193.0M
$546.0M
Q3 24
$99.0M
$582.0M
Q2 24
$216.0M
$566.0M
Gross Margin
CLX
CLX
CTSH
CTSH
Q1 26
Q4 25
43.2%
Q3 25
Q2 25
46.5%
Q1 25
44.6%
Q4 24
43.8%
Q3 24
45.8%
Q2 24
46.5%
Operating Margin
CLX
CLX
CTSH
CTSH
Q1 26
15.6%
Q4 25
16.0%
Q3 25
16.0%
Q2 25
20.6%
15.6%
Q1 25
15.2%
16.7%
Q4 24
14.1%
14.8%
Q3 24
10.0%
14.6%
Q2 24
14.5%
14.6%
Net Margin
CLX
CLX
CTSH
CTSH
Q1 26
12.2%
Q4 25
9.4%
12.2%
Q3 25
5.1%
Q2 25
16.7%
12.3%
Q1 25
11.2%
13.0%
Q4 24
11.4%
10.7%
Q3 24
5.6%
11.5%
Q2 24
11.4%
11.7%
EPS (diluted)
CLX
CLX
CTSH
CTSH
Q1 26
$1.39
Q4 25
$1.29
$1.35
Q3 25
$0.56
Q2 25
$2.68
$1.31
Q1 25
$1.50
$1.34
Q4 24
$1.54
$1.10
Q3 24
$0.80
$1.17
Q2 24
$1.74
$1.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLX
CLX
CTSH
CTSH
Cash + ST InvestmentsLiquidity on hand
$1.5B
Total DebtLower is stronger
$568.0M
Stockholders' EquityBook value
$15.1B
Total Assets
$20.5B
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLX
CLX
CTSH
CTSH
Q1 26
$1.5B
Q4 25
$227.0M
$1.9B
Q3 25
$2.4B
Q2 25
$167.0M
$1.8B
Q1 25
$226.0M
$2.0B
Q4 24
$290.0M
$2.2B
Q3 24
$278.0M
$2.0B
Q2 24
$202.0M
$2.2B
Total Debt
CLX
CLX
CTSH
CTSH
Q1 26
$568.0M
Q4 25
Q3 25
Q2 25
$2.5B
Q1 25
Q4 24
Q3 24
Q2 24
$2.5B
Stockholders' Equity
CLX
CLX
CTSH
CTSH
Q1 26
$15.1B
Q4 25
$-125.0M
$15.0B
Q3 25
$14.9B
Q2 25
$321.0M
$15.3B
Q1 25
$27.0M
$14.9B
Q4 24
$-41.0M
$14.4B
Q3 24
$60.0M
$14.5B
Q2 24
$328.0M
$13.9B
Total Assets
CLX
CLX
CTSH
CTSH
Q1 26
$20.5B
Q4 25
$5.6B
$20.7B
Q3 25
$20.1B
Q2 25
$5.6B
$20.2B
Q1 25
$5.5B
$20.0B
Q4 24
$5.6B
$20.0B
Q3 24
$5.5B
$20.2B
Q2 24
$5.8B
$18.6B
Debt / Equity
CLX
CLX
CTSH
CTSH
Q1 26
0.04×
Q4 25
Q3 25
Q2 25
7.74×
Q1 25
Q4 24
Q3 24
Q2 24
7.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLX
CLX
CTSH
CTSH
Operating Cash FlowLast quarter
$274.0M
Free Cash FlowOCF − Capex
$637.0M
$198.0M
FCF MarginFCF / Revenue
13.3%
3.7%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
0.41×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLX
CLX
CTSH
CTSH
Q1 26
$274.0M
Q4 25
$858.0M
Q3 25
$1.2B
Q2 25
$294.0M
$398.0M
Q1 25
$286.0M
$400.0M
Q4 24
$180.0M
$920.0M
Q3 24
$221.0M
$847.0M
Q2 24
$340.0M
$262.0M
Free Cash Flow
CLX
CLX
CTSH
CTSH
Q1 26
$637.0M
$198.0M
Q4 25
$781.0M
Q3 25
$1.2B
Q2 25
$219.0M
$331.0M
Q1 25
$233.0M
$323.0M
Q4 24
$127.0M
$837.0M
Q3 24
$182.0M
$791.0M
Q2 24
$259.0M
$183.0M
FCF Margin
CLX
CLX
CTSH
CTSH
Q1 26
13.3%
3.7%
Q4 25
14.6%
Q3 25
21.4%
Q2 25
11.0%
6.3%
Q1 25
14.0%
6.3%
Q4 24
7.5%
16.5%
Q3 24
10.3%
15.7%
Q2 24
13.6%
3.8%
Capex Intensity
CLX
CLX
CTSH
CTSH
Q1 26
2.5%
Q4 25
1.4%
Q3 25
1.2%
Q2 25
3.8%
1.3%
Q1 25
3.2%
1.5%
Q4 24
3.1%
1.6%
Q3 24
2.2%
1.1%
Q2 24
4.3%
1.6%
Cash Conversion
CLX
CLX
CTSH
CTSH
Q1 26
0.41×
Q4 25
1.32×
Q3 25
4.48×
Q2 25
0.89×
0.62×
Q1 25
1.54×
0.60×
Q4 24
0.93×
1.68×
Q3 24
2.23×
1.46×
Q2 24
1.57×
0.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons